References
- Walling AD, Dickson G. Guillain-Barré syndrome. Am Fam Physician 2013;87:191–7.
- Newswanger DL, Warren CR. Guillain-Barré syndrome. Am Fam Physician 2004;69:2405–10.
- Rajabally YA, Uncini A. Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2012;83:711–8.
- Witsch J, Galldiks N, Bender A, et al. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. J Neurol 2013;260:1367–74.
- Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011;36:123–33.
- Huang W-C, Lu C-L, Chen SC-C. A 15-year nationwide epidemiological analysis of Guillain-Barré syndrome in Taiwan. Neuroepidemiology 2015;44:249–54.
- Domínguez-Moreno R, Tolosa-Tort P, Patiño-Tamez A, et al. Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario mexicano. Rev Neurol 2014;58:4–10.
- Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain–Barré syndrome incidence and mortality rates in US hospitals. Neurology 2008;70: 1608–13.
- Van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology 2013;80:1650–4.
- Inokuchi H, Yasunaga H, Nakahara Y, et al. Effect of rehabilitation on mortality of patients with Guillain-Barre Syndrome: a propensity matched analysis using nationwide database. Eur J Phys Rehabil Med 2014;50:439–46.
- Sedano MJ, Calleja J, Canga E, Berciano J. Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand 1994;89:287–92.
- Piñol-Ripoll G, Larrodé Pellicer P, Garcés-Redondo M, et al. Características del síndrome de Guillain-Barré en el área III de salud de la Comunidad Autónoma de Aragón. An Med Interna 2008;25:108–12.
- Aladro-Benito Y, Conde-Sendin MA, Muñoz-Fernández C, et al. Síndrome de Guillain-Barré en el área norte de Gran Canaria e isla de Lanzarote. Rev Neurol 2002;35:705–10.
- McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology 2009;32:150–63.
- Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series No 31. Geneva: World Health Organization; 2001.
- Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335–51.
- Spanish Rare Diseases Registries Research Network-SpainRDR. Available from: http://spainrdr.isciii.es/en [accessed 27 Mar 2015].
- Cuadrado JI, de Pedro-Cuesta J, Ara JR, et al. Guillain-Barré syndrome in Spain, 1985–1997: epidemiological and public health views. Eur Neurol 2001;46:83–91.
- Cuadrado JI, de Pedro-Cuesta J, Ara JR, et al. Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists. Neurol Sci 2004;25:57–65.
- Wong AHY, Umapathi T, Shahrizaila N, et al. The value of comparing mortality of Guillain-Barré syndrome across different regions. J Neurol Sci 2014;344:60–2.
- Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011;36:123–33.
- Rajabally YA, Uncini A. Outcome and its predictors in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 2012;83:711–8.
- Hughes RAC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2014;9:CD002063.
- Raphaël JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2012;7:CD001798.